Phibro Animal Health | PAHC - 净收入

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.31B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	净收入	更改		日
Align Technology	USD 112.77M		22.99M	2026-03
ANI Pharmaceuticals	USD 29.49M		2.86M	2026-03
Assertio Holdings	USD -2.92M		753K	2024-09
Aurora Cannabis	CAD 1.82M		53.29M	2025-12
Bristol-Myers Squibb	USD 2.68B		1.59B	2026-03
Canopy Growth	CAD -62.63M		60.99M	2025-12
Corcept Therapeutics	USD -31.76M		56.05M	2026-03
Eli Lilly	USD 7.4B		760M	2026-03
Henry Schein	USD 107M		6M	2026-03
Idexx Laboratories	USD 278.45M		30.26M	2026-03
Knight Therapeutics	CAD -3.79M		8.83M	2025-09
Merck	USD -4.24B		7.2B	2026-03
Nektar Therapeutics	USD -36.08M		978K	2025-12
Pacira	USD 2.92M		1.28M	2026-03
Phibro Animal Health	USD 27.46M		932K	2025-12
Prestige Brands	USD 46.7M		22.44M	2025-12
Supernus Pharmaceuticals	USD -2.29M		1.81M	2026-03
Zoetis	USD 601M		2M	2026-03